Welcure Drugs and Pharmaceuticals Limited (BSE: 524661)
Health Care · Pharmaceuticals · IN
Rs0.20
-4.76% today · -71.3% 1Y
Welcure Drugs and Pharmaceuticals Limited (BSE: 524661) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.55M.
Over the last twelve months the share price has lost 71.3%, trading between 0.19 and 0.81.
Tweenvest scores Welcure Drugs and Pharmaceuticals Limited across four factors: quality 59/100, value 68/100. Its strongest factor is value.
524661 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.55M
- Revenue (TTM)
- $38.98M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- -0.43
- 52-week high
- Rs0.81
- 52-week low
- Rs0.19
- Avg volume (3M)
- —
- Shares outstanding
- 1.24B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Nexalis Therapeutics LimitedASX: NX1 | $2.67M | AU$— | — |
| IM Cannabis Corp.NasdaqCM: IMCC | $2.60M | $1.43 | -9.49% |
| SciSparc Ltd.NasdaqCM: SPRC | $2.60M | $4.20 | -6.04% |
| XORTX Therapeutics Inc.NasdaqCM: XRTX | $2.56M | $1.70 | +20.57% |
| Argent BioPharma LimitedASX: RGT | $2.55M | AU$0.03 | +3.33% |
| Cai Lay Veterinary Pharmaceutical Joint Stock CompanyHNX: MKV | $2.54M | ₫13,200.00 | +10.00% |
| Double Bond Pharmaceutical International AB (publ)XSAT: DBP B | $2.51M | Skr0.11 | +3.70% |
| Jaguar Health, Inc.NasdaqCM: JAGX | $2.49M | $4.65 | -2.92% |
Figures last refreshed Oct 11, 2026.